Purpose: To evaluate the additional intraocular pressure lowering efficacy and safety of travoprost 0.004% compared with la-tanoprost 0.005%, in patients with open-angle glaucoma or ocular hypertension, whose intraocu...Purpose: To evaluate the additional intraocular pressure lowering efficacy and safety of travoprost 0.004% compared with la-tanoprost 0.005%, in patients with open-angle glaucoma or ocular hypertension, whose intraocular pressure was not adequately controlled on timolol 0.5% twice daily. Methods: A total of 30 patients with open-angle glaucoma or ocular hypertension were included in a six months, open-label, randomised study. All pa-展开更多
Purpose: to evaluate the efficacy and safety of bimatoprost as alternative to filtration surgery in patients with uncontrolled glaucoma on maximal tolerable medical therapy (MTMT). Methods: 83 consecutive patients (83...Purpose: to evaluate the efficacy and safety of bimatoprost as alternative to filtration surgery in patients with uncontrolled glaucoma on maximal tolerable medical therapy (MTMT). Methods: 83 consecutive patients (83 eyes), recruited from the waiting lists for glaucoma surgery of 8 ophthalmic centers. All the patients were scheduled for surgery because of inefficacy of the MTMT, and/or a progressive deterioration of the visual field.展开更多
文摘Purpose: To evaluate the additional intraocular pressure lowering efficacy and safety of travoprost 0.004% compared with la-tanoprost 0.005%, in patients with open-angle glaucoma or ocular hypertension, whose intraocular pressure was not adequately controlled on timolol 0.5% twice daily. Methods: A total of 30 patients with open-angle glaucoma or ocular hypertension were included in a six months, open-label, randomised study. All pa-
文摘Purpose: to evaluate the efficacy and safety of bimatoprost as alternative to filtration surgery in patients with uncontrolled glaucoma on maximal tolerable medical therapy (MTMT). Methods: 83 consecutive patients (83 eyes), recruited from the waiting lists for glaucoma surgery of 8 ophthalmic centers. All the patients were scheduled for surgery because of inefficacy of the MTMT, and/or a progressive deterioration of the visual field.
